iSpecimen Inc. Secures Suppliers for hMPV Amid Growing Concerns of COVID-Style OutbreakOn January 16, 2025, iSpecimen Inc. (NASDAQ: ISPC) made a significant announcement regarding its strategic move to secure suppliers for the flu-like human metapneu

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read iSpecimen’s 8K filing here.

About iSpecimen

(Get Free Report)

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.

Featured Stories